Optimize your recovery journey with SUD treatment combined with integrative chiropractic care, focusing on holistic wellness and support.

Educational Abstract: Integrative Care Transitions and New Frontiers in Substance Use Disorder Treatment – An Evidence-Based, Multidisciplinary Approach in El Paso, Texas

As Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, I present an educational post that reframes our original transcript in first person and guides you through a comprehensive, easy-to-read journey into the evolving landscape of substance use disorder (SUD) care. I elaborate on nurse practitioners’ unique role across settings, practical strategies for care transitions, best practices for integrating primary care and specialty treatment, inpatient addiction consult services, and cutting-edge research shaping the field. I explain exactly how our multidisciplinary team at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, integrates chiropractic care with medical oversight from Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), alongside functional medicine, personal injury care, rehabilitation, and evidence-based SUD services.

I detail physiological mechanisms underlying SUD, pharmacotherapies, pain modulation, neurobiology of habit and relapse, and integrative protocols. This post highlights modern methods from leading researchers using rigorous, evidence-based practices and showcases actionable frameworks, systems redesign, and real-world cases. My clinical observations from sciatica.clinic and professional notes on LinkedIn inform practical strategies that unify musculoskeletal care, mental health, and addiction medicine to improve outcomes, reduce stigma, and support recovery across care transitions. The content that follows thoroughly details why and how each technique is used, offers step-by-step reasoning, and provides APA-7 style citations and linked references (ASAM, n.d.; SAMHSA, n.d.; NIDA, 2018; Volkow et al., 2016; SAMHSA, 2021; Babor et al., 2007; Carroll & Weiss, 2017; Degenhardt et al., 2018; American College of Obstetricians and Gynecologists, n.d.; Centers for Disease Control and Prevention, n.d.; JAMA Network, n.d.; Nature, n.d.; Institute for Functional Medicine, n.d.; BMJ, n.d.).

Integrative Substance Use Disorder Care: My Perspective as a Chiropractor and Nurse Practitioner

I am Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. Over my decades of practice, I’ve seen how substance use disorders disrupt health trajectories, worsen pain, compound metabolic and neuroimmune dysfunction, and destabilize social systems. My goal is to present a patient-centered, scientifically grounded approach that integrates primary care, addiction medicine, functional medicine, and integrative chiropractic care, while ensuring safety and quality through internal medicine oversight.

At Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, our model is multidisciplinary—common in both integrative and injury clinics—where an MD provides medical direction alongside chiropractic care. I am honored to work with Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine, NPI #1164426749, Texas MD License #J2933), who serves as our Medical Director and Collaborative Physician. With more than 40 years of experience as an internist, Dr. Cardenas directs diagnostics, medication management, hospital transitions, and complex comorbid care, while I lead integrative chiropractic, functional medicine evaluations, neuromusculoskeletal rehab, and pain modulation strategies. Together, we co-manage patients across levels of care, emphasizing safe transitions, eliminating barriers, and scaling treatment based on the ASAM Levels of Care (ASAM, n.d.).

This educational post reframes our original content in first-person and expands it with integrative care insights: how nurse practitioners drive SUD access, how we design transitions between inpatient, outpatient, and community services, how we use evidence-based pharmacotherapies like buprenorphine and methadone (SAMHSA, 2021), how behavioral and peer supports are co-located and coordinated, how our chiropractic care and rehab reduce pain-related triggers for relapse, and how we align harm reduction, addiction consult services, telehealth bridges, and contingency management with continuity of care (Babor et al., 2007; Carroll & Weiss, 2017).

The Role of Nurse Practitioners in Substance Use Disorder Care: A Frontline Perspective

From my vantage point as a clinician straddling chiropractic medicine and advanced practice nursing, I’ve witnessed the transformative role nurse practitioners (NPs) play across the SUD continuum. With over 258,000 NPs practicing nationwide and rapid growth expected, NPs are uniquely placed to provide entry points into treatment, particularly in primary care, rural settings, and underserved areas.

• Key strengths of NP-led SUD care:

• • Patient autonomy and self-determination: We emphasize shared decision-making, which is critical for SUD engagement.
  • Prevention and health education: We deliver consistent, non-stigmatizing counseling, including motivational interviewing (Carroll & Weiss, 2017).
  • Scope for controlled medications: In most states, NPs can prescribe buprenorphine without an X-waiver, removing a major barrier to OUD treatment (SAMHSA, 2021).
  • Continuity and longitudinal relationships: These relationships let us tailor interventions to the stage of change, aligning care intensity and support accordingly (Babor et al., 2007).

I find NPs excel in harm-reduction conversations, risk mitigation, and connecting medical care with social variables that drive SUD—a vital skill set when pain, trauma, depression, or instability are present. While curricular time for SUD might be limited in some NP programs, advanced training exists, including Certified Addiction Registered Nurse – Advanced Practice (CARN-AP) and psychiatric mental health NP pathways with dedicated SUD competencies. When NPs function within integrated teams, with medical direction from internal medicine, and seamless links to chiropractic and rehabilitation, we see improved access, engagement, and retention across the continuum (JAMA Network, n.d.).

Why Patients View Healthcare as a Risk Environment: Understanding Stigma and Its Clinical Consequences

Patients often perceive healthcare as risky due to stigma, discrimination, fear of punitive responses, and mistrust (NIDA, 2018). These perceptions lead to:

• Delayed care and presentation with acute, advanced illness
• Underreporting or non-disclosure of substance use
• Avoidance of pain management or inadequate analgesia
• Self-directed discharges before completing treatment

Clinically, stigma correlates with higher morbidity, mortality, and overall health system costs (Volkow et al., 2016). As providers, we must convert healthcare from a perceived risk environment into a trust environment. In my practice, this means non-judgmental communication, dignity-preserving policies, peer support, and warm handoffs. It also means integrating chiropractic and rehabilitative services to reduce pain triggers, so patients aren’t forced to choose between untreated pain and illicit coping. Trust-building accelerates disclosure, engagement, and continuity—all foundational to evidence-based outcomes.

Mapping SUD Care Settings: Primary Care at the Center with Coordinated Auxiliaries

In our model, I place primary care at the center, with auxiliary paths configured to the patient’s ASAM level of care and biopsychosocial needs (ASAM, n.d.):

• Outpatient primary care with on-site pharmacotherapy for OUD (e.g., buprenorphine), mental health integration, and chiropractic pain management
• Hospital or inpatient care with addiction consult services for initiation/stabilization and transition planning
• Emergency departments with bridge-to-community pathways
• Specialty SUD treatment: intensive outpatient (IOP), residential rehab, office-based addiction treatment (OBAT), and opioid treatment programs (OTPs) for methadone
• Peer support networks: Onsite and community-based
• Telehealth and bridge clinics: For continuity, high-frequency contact, and rapid troubleshooting

We personalize transitions based on ASAM criteria, a strength-based, multidimensional approach that assesses needs, obstacles, assets, and supports. I treat the ASAM framework as a living map for care escalation and de-escalation, ensuring the right care at the right time (ASAM, n.d.). Integrated operations—shared records, unified care plans, co-located services—reduce friction and reinforce continuity.

Primary Care as the SUD Entry Point: Longitudinal Relationships and Stage of Change

Primary care is the largest clinical workforce and often the first contact. The value lies in sustained relationships that make it possible to meet patients where they are (Babor et al., 2007):

• Prec: Non-judgmental listening, basic harm reduction, safety planning
• Contemplation: Education on risks, benefits, and available treatments; motivational interviewing; pain alternatives
• Preparation: Aligning logistics (pharmacy, insurance, transportation), scheduling peer support and counseling
• Action: Medication initiation, frequent follow-ups, rehab plans
• Maintenance: Structured coaching, relapse prevention, addressing pain, mood, and social determinants

In my experience, integrating chiropractic assessments—posture, gait, joint dynamics—with functional medicine (inflammation, nutrition, sleep, endocrine) can clarify root drivers and set realistic treatment intensity. Pain related to lumbar radiculopathy, myofascial dysfunction, or postural strain is a common relapse trigger; addressing it quickly can stabilize recovery trajectories. For clinical observations on sciatica-related pain and integrative strategies I routinely apply, see sciatica.clinic and my professional updates on LinkedIn:

• https://sciatica.clinic/
• https://www.linkedin.com/in/dralexjimenez/

Addressing Primary Care Constraints: Workforce Shortages and Practical Barriers

The US faces a significant primary care workforce gap, with millions living in health professional shortage areas (JAMA Network, n.d.). Providers juggle time constraints, lower reimbursement for SUD services, limited psychosocial referral options, concerns about diversion, and sometimes requirements for concurrent counseling that create barriers (SAMHSA, 2021). To counter, we:

• Build team-based models with nurse care managers as primary contacts for buprenorphine patients.
• Co-locate services: pharmacy, mental health, chiropractic, rehab, and peer support
• Use protected time and continuing education to support providers and empower SUD champions.
• Leverage national resources like PCSS for mentoring and on-demand consultations.

I have found that aligning care plans with pain relief, sleep improvement, and stress modulation dramatically increases adherence. Patients remain engaged when they see results quickly and feel their team is coordinated and compassionate.

Best Practices: Integrated Primary Care Programs for OUD Treatment

Evidence from integrated primary care models shows four core components (JAMA Network, n.d.; SAMHSA, 2021):

• Pharmacologic therapy: On-site prescribing of buprenorphine and adjunct medications
• Co-located psychosocial services: Behavioral counseling, CBT pain groups, peer support
• Integrated operations: One location, unified records, shared care plans
• Education/outreach: Patient-facing materials, motivational strategies, harm-reduction training

Team-based approaches—especially nurse care managers handling proactive follow-up, medication coordination, and urine toxicology—reduce friction, increase continuity, and improve outcomes. In my clinic, integrating chiropractic care offers non-opioid pain control, improves mobility, and lowers musculoskeletal drivers that worsen withdrawal distress or cravings.

Case Study: Restarting Buprenorphine in Primary Care with Co-Located Services

James, a 52-year-old man with diabetes and chronic pain, presented to primary care after returning to illicit fentanyl use. He wanted to restart buprenorphine. We used a shared decision-making approach, discussed risks/benefits, and selected high-dose initiation to overcome potent fentanyl’s binding and high tolerance profile (SAMHSA, 2021). We coordinated a prescription to a co-located pharmacy, scheduled a telehealth check-in, and lined up counseling and CBT pain group enrollment.

• Early follow-up was critical: High-dose initiation requires reaching moderate to severe withdrawal before starting. He struggled but felt better soon after starting; we adjusted dosing and connected him to peer support.
• Over weeks, he transitioned successfully, held regular nurse care manager visits, and addressed depression and pain drivers.

My clinical observation: When pain, depression, and sleep are addressed immediately—through integrative chiropractic adjustments, neuromuscular therapies, and endocrine/metabolic support—patients report less craving intensity and more stability. Co-located services and warm handoffs are decisive; they transform siloed care into a team experience.

Specialty SUD Treatment: Indications, Access, and Equitable Medical Care

Some patients require higher intensity support beyond primary care:

• Intensive outpatient programs (IOP)
• Residential or inpatient rehab
• OBAT clinics and OTPs for methadone

Crucially, medical treatment should not be contingent on behavioral program participation. Initiating buprenorphine or naltrexone should proceed when clinically indicated, with psychosocial interventions offered but not gatekeeping access to pharmacotherapy. This principle reduces mortality and aligns with evidence-based practice (SAMHSA, 2021; JAMA Network, n.d.).

Acute Care Opportunities: Inpatient Addiction Consult Services

Hospital admissions create teachable moments where patients reevaluate goals and accept treatment. Addiction consult services (ACS)—interdisciplinary teams of addiction medicine clinicians, social workers, care coordinators, and peer specialists—improve outcomes: fewer readmissions and more starts/continuation of MOUD (JAMA Network, n.d.; SAMHSA, 2021).

ACS performs:

• Medical assessment and initiation/titration of methadone or buprenorphine
• Pain management strategies appropriate for SUD patients
• Therapeutic interventions and post-discharge linkages
• Hospital policy improvements, provider education, and system-wide quality initiatives

I consider ACS a cornerstone for safe transitions, especially when complex infections, withdrawal syndromes, or polysubstance use are present. Integrative chiropractic planning post-discharge can accelerate recovery by restoring biomechanical function and reducing nociceptive input that perpetuates stress physiology and craving.

Case Study: Inpatient Management with ACS – Low-Dose Buprenorphine Initiation and Harm Reduction

Lisa, 32, presented with left lower extremity cellulitis, daily fentanyl (IV and inhaled) and methamphetamines, withdrawal onset, and active hepatitis C. She had concerns about her dog’s care—a real barrier to staying hospitalized.

Within 24 hours:

• The ACS medical provider diagnosed severe OUD and stimulant use disorder, started methadone for withdrawal management, with plans to transition to buprenorphine via low-dose (microdosing) initiation to avoid precipitated withdrawal (Socias et al., 2021).
• The social worker performed the ASAM assessment, used motivational interviewing to reduce the chance of self-directed discharge, and began referrals for post-discharge treatment.
• The peer specialist addressed immediate social needs (dog care, communication, phone) and established trust.

Outcomes:

• Methadone stabilized withdrawal; buprenorphine microdosed safely
• IV antibiotics for cellulitis
• Referral for HCV treatment
• Education on harm reduction: naloxone access, risks of contaminated supply (fentanyl in stimulants), not using alone, infection risk from paraphernalia sharing
• Discussion of contingency management for stimulant use and off-label medication options to moderate cravings (Carroll & Weiss, 2017)

Clinically, Lisa’s case shows a pattern: once withdrawal is controlled and pain addressed, the patient’s capacity for executive function, planning, and engagement improves (Volkow et al., 2016). Pairing hospital-based initiation with warm transitions to community and integrative chiropractic pain strategies reduces relapse risk.

Locating SUD Treatment: Practical Tools

For locating regional treatment agencies and prescribers:

• SAMHSA Treatment Locator: Comprehensive listing of agencies (SAMHSA, n.d.)
• Buprenorphine prescriber directories: Although the X-waiver is gone, curated lists still help identify addiction-experienced prescribers (SAMHSA, 2021)

These tools help us construct transitions that are geographically feasible and timely, key determinants of success.

Care Transitions: Challenges and Best Practices from Acute to Community Settings

Transitions—hospital to outpatient, outpatient to IOP/residential, or telehealth to in-person—can fracture continuity. Common barriers include care silos, stigma, staff shortages, transportation, technology access, and insurance barriers (JAMA Network, n.d.). Best practices include:

• Leveraging partnerships: Build pre-existing relationships; map referral pathways with shared communication protocols
• Warm handoffs: Introductions between patient and new provider, ideally in person or by live video/phone
• Bridge appointments: Schedule within 24–72 hours post-discharge
• Care coordinators/nurse care managers: Proactive contact, problem-solving, appointment reminders
• Peer support continuity: Maintain peer contact across transitions
• Medication continuity plans: Ensure adequate supply and reconciliation
• Harm reduction kits: Naloxone, fentanyl test strips where available, wound care supplies
• Transportation and telehealth access: Provide vouchers, devices, or app support

My integrative spin: Add chiropractic/rehab visits early in transitions to deliver fast pain relief, reduce muscle guarding, and normalize movement biomechanics. Rapid improvements in pain and sleep during the first two weeks of transition correlate with lower relapse rates in my clinical observations (BMJ, n.d.; Institute for Functional Medicine, n.d.). See additional insights at https://sciatica.clinic/.

Physiological Underpinnings: Why Integrative Care Works in SUD

To design rational treatments, we must understand SUD physiology (NIDA, 2018; Volkow et al., 2016):

• Neurobiology of addiction:

• • Mesolimbic dopamine dysregulation (ventral tegmental area to nucleus accumbens) shifts salience toward drug cues
  • Prefrontal cortex hypofunction impairs executive control, planning, and impulse regulation
  • Amygdala and extended amygdala: Stress reactivity increases, sensitizing to withdrawal and cues
  • Glutamatergic plasticity: Learning circuits consolidate maladaptive habits

• Opioid receptor dynamics:

• • Mu-opioid receptor occupancy and tolerance complicate induction strategies, particularly with high-potency fentanyl
  • Buprenorphine’s partial agonism stabilizes receptors, reduces cravings, and provides a ceiling effect for respiratory depression (SAMHSA, 2021)
  • Methadone’s full agonism: Effective for severe tolerance and stabilizing high-dependence cases

• Withdrawal physiology:

• • Noradrenergic hyperactivity (locus coeruleus), autonomic dysregulation, GI distress, pain sensitivity, sleep disruption
  • Opioid-induced hyperalgesia due to neuroplastic changes

• Pain mechanisms:

• • Nociceptive, neuropathic, and nociplastic contributors; central sensitization amplifies pain signals (BMJ, n.d.)
  • Musculoskeletal dysfunction increases afferent nociception, elevates stress hormones, and perpetuates cravings.

• Inflammation and immune signaling:

• • Chronic substance use elevates pro-inflammatory cytokines; gut dysbiosis, HPA axis disruption, and mitochondrial stress degrade resilience (Institute for Functional Medicine, n.d.)

• Metabolic and endocrine:

• • Sleep loss, cortisol irregularities, insulin resistance, and low-grade inflammation amplify pain and mood symptoms (Centers for Disease Control and Prevention, n.d.)

• Psychological and social determinants:

• • Trauma history, depression, anxiety, isolation, housing insecurity, and legal barriers influence relapse risk (Babor et al., 2007)

Integrative chiropractic care modulates proprioceptive input, decreases mechanical nociception, and facilitates parasympathetic restoration. Combined with functional medicine approaches (nutrition, micronutrient repletion, sleep hygiene, stress management), the integrative plan reduces hyperalgesia, calms the HPA axis, and improves executive function to sustain behavior change (BMJ, n.d.; Institute for Functional Medicine, n.d.).

Why Specific Techniques Are Used: Reasoning Behind Protocols

• High-dose buprenorphine initiation: With fentanyl exposure, mu receptor dynamics often require higher initial doses to displace fentanyl and control cravings/withdrawal. High-dose starts, when done with proper monitoring, reduce oscillation between withdrawal and intoxication (SAMHSA, 2021).
• Low-dose (microdosing) buprenorphine: In hospitalized patients or those on methadone, microdosing slowly increases buprenorphine to avoid precipitated withdrawal, stabilizing the transition with fewer distress events (Socias et al., 2021).
• Methadone initiation in OTP or hospital: For high tolerance and instability, methadone provides full agonist stabilization, enabling functional recovery and eventual transitions where appropriate (SAMHSA, 2021).
• Harm reduction: Naloxone, test strips, and safe-use education reduce mortality and build trust, anchoring patients for further care (Centers for Disease Control and Prevention, n.d.).
• Contingency management: Evidence supports CM for stimulant use disorder; it leverages behavioral economics with rewards that reinforce non-use behaviors (Carroll & Weiss, 2017).
• Nurse care management: Frequent, predictable contact counters the chaos of early recovery; improves adherence and offers rapid troubleshooting (JAMA Network, n.d.).
• Chiropractic manual therapy: Reduces nociceptive load, normalizes joint mechanics, and facilitates muscle balance, decreasing pain triggers that drive relapse (BMJ, n.d.).
• CBT pain groups: Cognitive reframing, pacing strategies, and self-efficacy reduce catastrophic thinking and improve function (Carroll & Weiss, 2017).
• Peer support: Lived experience increases credibility and addresses non-medical obstacles quickly, enabling adherence to medical plans (JAMA Network, n.d.).
• Functional medicine adjuncts: Nutritional support (omega-3s, magnesium, vitamin D), gut health, sleep optimization, and stress modulation improve neuroimmune resilience (Institute for Functional Medicine, n.d.).

Our Multidisciplinary Setup in El Paso: Medical Direction and Integrative Chiropractic Care

At Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic), El Paso, Texas:

• Medical director: Maria Guadalupe Cardenas, MD (Internal Medicine; NPI #1164426749; Texas MD License #J2933), oversees medical safety, diagnostics, complex comorbidities, prescription oversight, and transitions requiring hospital or specialty linkage.
• Chiropractic integration: I provide adjustments, soft tissue work, neuromuscular rehabilitation, postural correction, and movement re-education tailored for patients with SUD, chronic pain, and injury care.
• Functional medicine and rehab: Nutritional and lifestyle interventions, physical reconditioning, and metabolic optimization.
• Personal injury care: Coordinated treatment plans addressing acute injuries, whiplash-associated disorders, and return-to-function strategies that accommodate concurrent SUD care.
• Behavioral and peer supports: Embedded or coordinated services to ensure psychotherapeutic continuity and social stability.
• Care coordinators and nurse care managers: Appointment coordination, medication management, and rapid response to emerging issues.

This setup mirrors the integrative or injury clinic model where MD direction provides a safety backbone, while chiropractic and rehabilitative services deliver non-opioid pain relief and restore function—a synergy essential for patients with SUD and chronic pain (JAMA Network, n.d.; BMJ, n.d.).

Building Trust and Reducing Stigma: Communication Strategies That Work

I’ve learned that the right words—and the right posture—matter (NIDA, 2018; Volkow et al., 2016):

• Use non-stigmatizing language: “Substance use disorder,” “return to use,” “medications for OUD”
• Emphasize autonomy and collaboration: “Let’s decide together”
• Validate pain and struggle: Acknowledge suffering, normalize challenges, and avoid moralizing
• Offer choices and control: Between initiation methods, support modalities, and timing
• Follow through consistently: Reliability builds therapeutic alliance

Patients who feel respected are more likely to disclose use, request help early, and complete treatment. This is foundational for successful transitions.

Integrative Chiropractic Care in SUD: Clinical Rationale and Methods

I integrate chiropractic care to directly modulate pain and musculoskeletal stressors (BMJ, n.d.):

• Techniques:

• • Spinal adjustments: Optimize segmental mobility, reduce mechanical pain
  • Myofascial release and trigger point therapies: Decrease muscle hypertonicity and referred pain
  • Neuromuscular re-education: Improve motor control, reduce compensatory strain
  • Postural correction: Normalize load distribution, reduce nociceptive signaling
  • Lumbar and cervical stabilization: Target core and neck musculature for injury resilience

• Outcomes:

• • Lower nociceptive input and central sensitization
  • Improved sleep quality and stress recovery
  • Enhanced functional capacity and self-efficacy
  • Reduced reliance on illicit analgesics and improved adherence to MOUD

My sciatica clinic resources include specific protocols for lumbar radiculopathy, piriformis syndrome, and facet-mediated pain, which are common triggers for opioid misuse:

• https://sciatica.clinic/

Functional Medicine Additions: Modulating Neuroimmune and Metabolic Stress

I add functional medicine pillars to bolster recovery (Institute for Functional Medicine, n.d.):

• Nutrition:

• • Anti-inflammatory dietary patterns (omega-3s, phytonutrients)
  • Micronutrients that aid neuromuscular function (magnesium, vitamin D, B-complex)
  • Protein sufficiency to rebuild tissue and neurotransmitter precursors

• Sleep hygiene:

• • Consistent schedules, light management, caffeine timing, relaxation rituals

• Stress physiology:

• • Breathwork, mindfulness, graded exposure, biofeedback

• Gut health:

• • Fiber, probiotics, elimination of irritants that perpetuate inflammation

• Movement prescriptions:

• • Graded activity plans to reduce pain and build capacity without overloading

These interventions decrease inflammation, stabilize HPA axis, and improve mood, making relapse less likely.

Medication Strategies: Why and How We Choose

• Buprenorphine:

• • Partial agonist with high receptor affinity
  • Reduces cravings and withdrawal
  • Ceiling effect lowers overdose risk
  • High-dose or microdose pathways selected based on tolerance and current opioid exposure (SAMHSA, 2021)

• Methadone:

• • Full agonist suitable for severe dependence
  • Requires OTP or hospital-based dispensing
  • Provides powerful stabilization; transitions should be planned carefully (SAMHSA, 2021)

• Naltrexone:

• • Opioid antagonist, useful after detox, requires caution with pain management (SAMHSA, 2021)

• Adjuncts:

• • Clonidine, lofexidine for autonomic symptoms
  • Sleep aids, antiemetics, antidiarrheals, non-opioid analgesics

• Stimulant use disorder:

• • Contingency management is evidence-based
  • Off-label pharmacotherapies considered case-by-case with close monitoring (Carroll & Weiss, 2017)

We tailor medication choices to patient preference, medical complexity, risk profile, and care setting. Dr. Cardenas’ medical oversight ensures safety in polypharmacy, liver disease (e.g., HCV), and comorbidity management.

Care Coordination: Nurse Care Managers, Pharmacy Integration, and Telehealth

Effective coordination turns intentions into outcomes (JAMA Network, n.d.):

• Nurse care managers:

• • Provide high-frequency follow-ups
  • Manage refill schedules and urine toxicology
  • Troubleshoot side effects and barriers

• Pharmacy integration:

• • Co-located pharmacies expedite starts
  • Pharmacist consultations for dosing and interactions

• Telehealth bridges:

• • Frequent check-ins, video-based assessments
  • Rapid course corrections and crisis de-escalation

• Peer support continuity:

• • Text/phone support, appointment accompaniment
  • Resource navigation (housing, pets, transport)

Patients who receive predictable contact and fast solutions stay engaged and succeed more often.

Harm Reduction: Safety as the Foundation

Harm reduction is non-negotiable (Centers for Disease Control and Prevention, n.d.):

• Naloxone distribution and training
• Fentanyl test strips where legal
• Education not to use alone; recognize signs of overdose
• Wound care supplies and infection prevention guidance
• Safer supplies where programs exist; referrals to syringe services

These interventions save lives, build rapport, and create stepping stones toward deeper treatment.

Pain, Injury, and SUD: Integrative Treatment for Personal Injury Patients

In injury contexts:

• Acute pain, whiplash, and soft-tissue injury can escalate opioid exposure
• Early integrative chiropractic care reduces pain and restores function
• Behavioral supports and non-opioid analgesics prevent transition to dependence
• Functional rehabilitation—graded movement and stabilization—prevents chronicity

In our El Paso clinic, we apply integrative strategies immediately after injury to reduce the need for opioids and support recovery trajectories (BMJ, n.d.; Institute for Functional Medicine, n.d.).

Healthcare System Design: Reducing Silos and Creating Seamless Pathways

System-level improvements include (JAMA Network, n.d.):

• Shared care agreements across agencies
• Standardized warm handoff protocols
• Data-sharing with consent
• Rapid-access appointments for transitions
• Quality metrics: MOUD initiation rates, retention, readmission rates, patient-reported outcomes
• Provider education: Stigma reduction, induction strategies, pain management in SUD

I advocate for operational redesign that limits friction and substitutes trust for bureaucracy. ACS services catalyze these changes in hospital systems.

Advanced Topics: Fentanyl Era Adaptations, Polysubstance Use, and Innovative Models

• Fentanyl considerations:

• • Higher potency and lipophilicity complicate inductions
  • High-dose buprenorphine strategies and microdosing reduce precipitated withdrawal risk (SAMHSA, 2021; Socias et al., 2021)

• Polysubstance use:

• • Co-occurring stimulant use requires contingency management and tailored psychosocial strategies
  • Alcohol or benzodiazepine co-use demands careful sedation risk management (Carroll & Weiss, 2017)

• Tele-bridges and mobile MAT:

• • Bring services to patients; reduce no-show barriers (JAMA Network, n.d.)

• Digital therapeutics and apps:

• • CBT modules, craving tracking, adherence support (Nature, n.d.)

• Trauma-informed care:

• • Safety, choice, collaboration, trustworthiness, empowerment integrated into every encounter

These innovations meet patients where they live—flexible, responsive, and respectful.

Real-World Implementation: From Theory to Practice

To implement these ideas:

• Start with a needs assessment
• Build a small core team: NP, MD oversight, chiropractic, care coordination, peer specialist.
• Map regional referrals and partnerships
• Pilot an induction protocol with follow-up cadence
• Track simple metrics first: show rate, induction success, 30-day retention
• Scale co-located services as feasible

My clinic’s approach grew iteratively. Early wins in pain relief, sleep, and rapid induction built momentum and patient trust.

Patient Stories: Recovery Anchored in Function and Trust

I’ve seen patients regain their lives when:

• Pain is controlled with non-opioid strategies
• Buprenorphine stabilizes cravings and withdrawal
• Peer supports answer the phone at 9 pm on a hard night
• Chiropractic and rehab restore movement and confidence
• Functional medicine calms inflammation and improves sleep
• Warm handoffs make new settings feel safe

Function precedes resilience. Resilience sustains recovery.

My Clinical Observations: Sciatica, Radiculopathy, and SUD

From sciatica.clinic, I’ve documented patterns:

• Lumbar disc herniations with radiculopathy produce severe pain spikes; rapid spinal care and nerve gliding reduce flare intensity
• Piriformis syndrome mimics radiculopathy; targeted release and stabilization improve leg symptoms
• Facet joint pain responds to adjustments and postural correction
• These improvements reduce sleep fragmentation and stress reactivity, which lower craving intensity and improve MOUD adherence

References:

• https://sciatica.clinic/
• https://www.linkedin.com/in/dralexjimenez/

Integrating Evidence-Based Addiction Care With Chiropractic, Functional Medicine, and Collaborative Internal Medicine Oversight

I walk you through an integrative, patient-centered approach to SUD care with a focus on continuity between acute and community settings, care transitions, and multidisciplinary collaboration. I highlight how our team at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, operates with medical direction by Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), who serves as our Medical Director and Collaborative Physician. We integrate chiropractic care, functional medicine, personal injury care, rehabilitation, and psychosocial services to support patients across life stages, including peripartum individuals and adolescents, and justice-involved populations at high risk for overdose (American College of Obstetricians and Gynecologists, n.d.; Centers for Disease Control and Prevention, n.d.).

We cover:

• Continuity strategies: Bridge prescriptions, co-located services, telehealth options, and care navigation to reduce care disruption and improve retention (JAMA Network, n.d.).
• Special populations: Justice-involved individuals post-release, pregnant and postpartum patients, and adolescents—each with distinct risks and needs.
• Clinical protocols for MOUD: Buprenorphine and methadone safety in pregnancy, neonatal opioid withdrawal syndrome counseling, dosing adjustments across pregnancy and postpartum, and adolescent considerations (American College of Obstetricians and Gynecologists, n.d.; Centers for Disease Control and Prevention, n.d.; SAMHSA, 2021).
• Case study: A postpartum patient on buprenorphine with tailored recovery scaffolding involving social support, transport, housing, and NICU coordination.
• Emerging science: Ethical considerations of genetic testing for SUD risk and early signals for GLP-1 receptor agonists in reducing substance use-related harms (New England Journal of Medicine, n.d.).
• Integrative chiropractic: How manual therapy, neuromuscular rehabilitation, autonomic regulation, pain neuroscience education, and functional nutrition reduce pain, improve function, stabilize mood, and diminish relapse risk, coordinated under internal medicine oversight (BMJ, n.d.; Institute for Functional Medicine, n.d.).
• Continuity of care in our clinic: Warm handoffs, multidisciplinary rounding, risk stratification, and outcomes tracking using modern evidence-based methods (JAMA Network, n.d.).

Continuity Between Hospital and Community: Building Bridges That Retain Patients In Care

When a provider initiates buprenorphine during hospitalization, patients are most vulnerable at the point of discharge. Without continuity—medication supply, follow-up appointment availability, care navigation—many patients struggle to find services, lose momentum, and disengage. In our integrated model, we extend continuity across settings and modalities.

• Bridge prescriptions at discharge: We ensure patients receive a 2–4 week supply of buprenorphine or other MOUD to cover the transition to outpatient care.
• Care navigators and warm handoffs: We routinely coordinate a warm handoff to our bridge clinic, primary care, or specialized SUD services—sometimes scheduling while the patient is still inpatient or in the ED. Care navigators are essential for linking patients to transportation, insurance, and social supports (JAMA Network, n.d.).
• Co-located services: Whenever possible, we co-locate medical care, chiropractic therapy, mental health counseling, and social services under one roof to streamline access and increase retention.
• Patient preference in care modality and location: Telehealth is integral for patients with caregiving responsibilities, unstable housing, or limited transportation. Flexible clinic hours and virtual options increase engagement without compromising safety.
• Structured follow-up: Initial follow-up is typically within 48–72 hours of discharge for buprenorphine stabilization, with weekly check-ins during the first month and monthly thereafter, customized for the patient’s clinical picture.

Why this works:

• Human continuity: Trust formed with inpatient teams carries forward into the community. Patients who see a familiar provider or clinic soon after discharge are more likely to continue treatment.
• Physiological timing: For people with OUD, stabilization while neuroadaptation is underway—especially after abrupt cessation or changing tolerance (post-incarceration, postpartum)—is critical to prevent relapse and overdose (Volkow et al., 2016).
• System navigation: Care navigators remove barriers—transport, insurance reinstatement, childcare, FMLA forms—and reduce cognitive burden, allowing patients to focus on health.

Clinical observation: In our practice, continuity reduces early dropout and re-hospitalization, especially for patients discharged on buprenorphine who receive swift follow-up, tangible support, and clear next steps. When I combine chiropractic manual therapy for pain modulation with MOUD stabilization and psychosocial support, patients report lower craving intensity and improved day-to-day functioning.

Optimizing Your Wellness- Video

Integrative Clinic Structure: Internal Medicine Oversight and Chiropractic Care Working Together

At Injury Medical Clinic PA, our model reflects the integrated structure common in multidisciplinary clinics, where a physician provides medical direction and collaborates with chiropractic and rehabilitation providers.

• Medical Director: Dr. Maria Guadalupe Cardenas, MD

• • Oversees medical protocols, safety, MOUD initiation/titration, lab testing, and management of comorbidities (cardiometabolic risks, hepatic function, pregnancy care, and postpartum monitoring).
  • Ensures compliance with state and federal prescribing and reporting regulations, and guides risk mitigation during transitions.

• Chiropractic and Rehabilitation: Dr. Alex Jimenez, DC, APRN, FNP-BC

• • Focuses on biomechanical assessment, manual therapy, neuromuscular rehabilitation, pain neuroscience education, autonomic balancing techniques, and functional movement training.
  • Coordinates with medical and mental health teams to reduce pain drivers that contribute to relapse risk and poor retention.

• Functional Medicine and Nutrition

• • Addresses inflammation, sleep dysregulation, micronutrient deficits, and gut-brain axis factors that influence mood, craving, and recovery capacity.

• Mental Health and Social Supports

• • Integrates behavioral therapies, peer support, and social services (housing, food, transport) with care navigation.

• Personal Injury Care

• • Treats injury-related pain to remove physiological stressors that fuel substance use. For motor vehicle accidents and workers’ comp cases, we align pain management, rehabilitation, and legal documentation.

This alignment allows us to create personalized care plans that stabilize patients medically while strengthening musculoskeletal function, reducing pain, and optimizing resilience (BMJ, n.d.; JAMA Network, n.d.).

The Neurobiology of Continuity: Why Holding the Line Prevents Overdose and Improves Retention

SUD involves complex neuroadaptations in reward, stress, and executive systems (Volkow et al., 2016; NIDA, 2018):

• Reward circuitry: Chronic opioid use dysregulates the mesolimbic dopamine pathway (VTA to nucleus accumbens), driving compulsive use.
• Stress systems: The extended amygdala and CRF system become hyperactive under withdrawal and stress.
• Executive function: Prefrontal cortical networks (decision-making, impulse control) become hypoactive, impairing planning and increasing relapse vulnerability.

Continuity measures—bridge prescriptions, quick follow-ups, co-located services—reduce the window of acute vulnerability post-discharge, during which stress and cue-driven craving can overwhelm. Medication coverage maintains receptor occupancy (e.g., buprenorphine’s partial agonism at mu-opioid receptors). It reduces craving and withdrawal, while psychosocial supports buffer stress responses and enhance executive functioning through structured routines and supportive relationships.

Chiropractic care complements this by reducing nociceptive input and modulating autonomic tone:

• Manual therapy and spinal manipulation: Can influence descending pain inhibitory pathways, reduce central sensitization, and improve proprioceptive signaling, diminishing hypervigilance and stress reactivity (BMJ, n.d.).
• Breathing and vagal techniques: Enhance parasympathetic activity, lower sympathetic overdrive, and improve interoceptive regulation—factors linked to craving intensity and relapse risk (Institute for Functional Medicine, n.d.).
• Movement rehabilitation: Rebuilds confidence and function, decreasing disability and pain catastrophizing, which often drive self-medication behaviors (Carroll & Weiss, 2017).

In practical terms, the more seamless the transition, the fewer triggers a patient encounters, and the stronger the physiologic and behavioral stabilizers remain in place.

Co-Located Services and Patient Preference: Maximizing Access and Engagement

We design our services around real patient needs:

• Co-locating SUD treatment, mental health care, chiropractic, and social supports increases convenience and reduces fragmentation (JAMA Network, n.d.).
• Offering telehealth options for follow-up allows mothers, caregivers, and shift workers to maintain continuity when in-person care is not feasible.
• Flexible scheduling and post-discharge walk-in slots help ensure medications do not lapse and that support is immediately accessible.

Physiological impact:

• When stress load decreases (less travel, fewer bureaucratic steps), cortisol levels lower, and allostatic burden improves sleep, mood regulation, and cognitive bandwidth, critical for adherence and self-care (Centers for Disease Control and Prevention, n.d.).

Care Navigation: The Glue That Holds the System Together

Care navigators with deep knowledge of community resources assist with (JAMA Network, n.d.):

• Insurance reinstatement and coverage continuity
• Transportation vouchers and ride scheduling
• Childcare arrangements
• Housing referrals and transitional programs
• Appointments and warm handoffs
• Legal and reporting requirements clarification

The presence of navigators correlates with improved follow-up rates and lower emergency department utilization. They convert macro-level resources into micro-level actionable steps for the patient.

Special Focus: Justice-Involved Individuals and Post-Release Vulnerability

Overdose is a leading cause of death after release from carceral environments. Loss of opioid tolerance, disruption in continuity of care, and low access to MOUD are key drivers of mortality (Centers for Disease Control and Prevention, n.d.; SAMHSA, 2021).

Common post-release challenges:

• Loss of tolerance: A return to prior use amounts can be lethal. Patients need explicit counseling about lowered tolerance and overdose risk.
• Gaps in treatment access: Many jails and prisons do not offer MOUD, or they underdose, resulting in poor experiences and reduced willingness to engage later.
• Insurance loss: Coverage interruptions limit immediate access to medications and outpatient services.
• Stigma and self-worth: Internalized stigma reduces help-seeking and increases disengagement.

Our approach:

• Pre-release coordination when possible: Establish appointments and secure bridge prescriptions timed to release.
• Immediate post-release follow-up: Within 24–72 hours, prioritize MOUD initiation or re-initiation, naloxone distribution, and safety planning.
• Harm reduction education: Fentanyl contamination awareness, overdose recognition, naloxone use, and never use alone.
• Chiropractic integration: Address pain generators early to reduce motivation for opioid return; focus on gentle manual therapy, graded movement, and autonomic regulation.

Physiology and risk:

• Abrupt abstinence reduces receptor tolerance and shifts homeostatic set points; sudden re-exposure produces exaggerated respiratory depression risk. Buprenorphine’s ceiling effect and partial agonism can stabilize mu receptor occupancy, reducing overdose risk when properly initiated (SAMHSA, 2021; Volkow et al., 2016).

Special Focus: Peripartum Individuals, Prenatal Barriers, and Postpartum Transitions

Pregnant and postpartum individuals face heightened risk of overdose and multiple systemic barriers, including stigma and fears related to child custody (American College of Obstetricians and Gynecologists, n.d.; Centers for Disease Control and Prevention, n.d.). Many avoid care due to punitive policies and mandatory reporting concerns.

Key points we emphasize:

• Substance use during pregnancy is not equivalent to child maltreatment under federal definitions. The Comprehensive Addiction and Recovery Act (CARA) requires notification when an infant is born affected by substances, but this is not inherently a report of abuse/neglect; state policies vary (SAMHSA, n.d.).
• Punitive policies reduce engagement: Evidence shows stricter mandatory reporting correlates with later initiation of prenatal care, fewer adequate prenatal visits, and reduced postpartum follow-up.
• Support over criminalization: Treatment and wraparound support improve outcomes for mothers and infants.

Clinical counseling with compassion:

• I greet patients with appreciation: “Thank you for coming to see me.” By acknowledging obstacles, we create trust and de-escalate fear-based avoidance.
• We discuss risks honestly and offer evidence-based options: Buprenorphine and methadone are safe in pregnancy; uncontrolled withdrawal poses greater risks to mother and fetus than MOUD (American College of Obstetricians and Gynecologists, n.d.; SAMHSA, 2021).
• We explain neonatal opioid withdrawal syndrome (NOWS): It is a known risk; the severity is not dose-dependent; the best dose is the one that treats maternal cravings and withdrawal effectively.

Postpartum considerations:

• Metabolic shifts occur after birth and typically normalize over 3–12 weeks. Buprenorphine or methadone dose reductions should be individualized and conservative to avoid oversedation while maintaining control of cravings (Centers for Disease Control and Prevention, n.d.).
• Monitoring for sedation and respiratory depression during the postpartum period is warranted, especially as sleep deprivation, anemia, or co-medications may alter drug effects.
• Flexible postpartum follow-up: Telehealth check-ins, transport/childcare support, and warm handoffs to pediatric, lactation, and mental health providers strengthen the mother-baby dyad.

Chiropractic integration postpartum:

• Gentle manual therapy to address postural strain, pelvic floor–related mechanics (in collaboration with pelvic physical therapy), thoracic outlet and neck tension from feeding postures, and core stabilization.
• Autonomic balancing (breathing drills, rib mechanics, vagal tone enhancement) to lower anxiety and improve sleep.
• Functional nutrition strategies for replenishment: Iron, omega-3s, choline, magnesium, and protein adequacy to support mood and tissue recovery (Institute for Functional Medicine, n.d.).

Case Study: Postpartum Buprenorphine Management and Recovery Scaffolding

Patient scenario:

• Liz, a 32-year-old female, is one day postpartum with a baby girl. History of OUD and illicit fentanyl use; started on buprenorphine during pregnancy by primary care and titrated to 8 mg QID (total 32 mg/day) in the third trimester.
• The baby may be monitored in the NICU for NOWS.

Post-discharge priorities:

• Assess housing, transport, and social support to facilitate NICU visits and maternal follow-up.
• Provide flexible follow-up options, including telehealth.
• Counsel on postpartum metabolism: Dose reductions may be appropriate over weeks 3–12 depending on sedation and symptom control.
• Monitor cravings and withdrawal symptoms; adjust doses in small increments.
• Engage social work, peer support, mental health care, food resources, transportation, and housing support.
• Coordinate with pediatric and lactation services; consider mother-baby co-located visits when possible.

Chiropractic postpartum plan:

• Gentle spinal and rib cage work to improve breathing mechanics, reduce cervicothoracic pain, and optimize autonomic balance.
• Core stabilization with graded progressions to address diastasis and pelvic stability.
• Patient education on ergonomics for infant care to reduce musculoskeletal strain that could drive pain and relapse risk.

Outcome targets:

• Stabilize MOUD dosing to maintain function without oversedation.
• Reduce pain and fatigue load to lessen triggers for use.
• Strengthen the mother-infant bond with supportive scheduling and co-located services.

Adolescents and Young Adults: Tailored Care for Developing Brains

Adolescents differ from adults in neurodevelopment and social context (Nature, n.d.; Centers for Disease Control and Prevention, n.d.):

• The reward system matures early; the prefrontal cortex (planning, impulse control) continues developing into the mid-20s. Adolescents can experience intense reward but have limited executive moderation.
• Motivations include peer influence, low self-esteem, anxiety/depression, self-treatment, or weight control pressures.
• Polysubstance use and experimentation are common; daily dependence may be less frequent, but overdose risk remains high due to fentanyl contamination.
• Retention in SUD treatment is generally lower; parental involvement requirements vary by state law.

Medication considerations:

• Buprenorphine: First-line for adolescents/young adults; FDA-approved for ages 16+. Some clinicians use it off-label for ages 12–15 when the risk-benefit profile supports it (SAMHSA, 2021).
• Long-acting injectable buprenorphine: Limited evidence and not approved under 18.
• Naltrexone and methadone: Generally approved for 18+; careful deliberation needed in younger patients.
• For adolescents with episodic use and non-dependence, standard doses (e.g., 8 mg) may be too sedating; shared decision-making and careful titration are crucial.

Best practices:

• Wraparound services: Integrate mental health assessment to identify drivers (anxiety/depression), school support, family therapy, and peer support programs.
• Know state laws: Consent thresholds differ; respect adolescent autonomy while encouraging appropriate parental involvement.
• Naloxone distribution: Universal education and access can save lives.
• Harm reduction: Educate on fentanyl risks, counterfeit pills, and overdose prevention. Evidence suggests targeted education reduces willingness to misuse prescription drugs (Centers for Disease Control and Prevention, n.d.).

Chiropractic care for adolescents:

• Focus on sports-related injury prevention and rehabilitation, posture, and movement literacy to improve body awareness and reduce risky coping behaviors.
• Integrate motivational interviewing to align physical goals (sports, dance, work performance) with sobriety and health (Carroll & Weiss, 2017).

Medications for Opioid Use Disorder in Pregnancy: Dosing Rationale and Safety

Buprenorphine and methadone are safe in pregnancy, and the dangers of withdrawal often exceed the medication risks (American College of Obstetricians and Gynecologists, n.d.; SAMHSA, 2021). We counsel using clear, evidence-based language:

• Neonatal opioid withdrawal syndrome (NOWS): Risk is real but not dose-dependent; prioritize maternal control of cravings and withdrawal to stabilize pregnancy.
• Dose adjustments across trimesters: Increased volume of distribution and metabolic rates in late pregnancy may require higher doses.
• Postpartum dosing: Metabolism typically returns toward baseline within 3–12 weeks postpartum; adjust dosing based on sedation and symptom control, not by fixed calendar alone (Centers for Disease Control and Prevention, n.d.).

Physiology:

• Buprenorphine’s partial agonist profile provides receptor occupancy that reduces withdrawal and craving while limiting respiratory depression risk compared with full agonists (SAMHSA, 2021).
• Methadone’s full agonist potency requires careful titration, regular monitoring, and postpartum adjustments under medical oversight.

Care plan integration:

• Frequent postpartum check-ins to track sedation, cravings, sleep, and mood.
• Collaboration with lactation services and pediatric care.
• Chiropractic support for pain relief and autonomic regulation to reduce stress-related triggers.

Reporting and Legal Context: CARA, State Policies, and Patient Trust

Providers often fear noncompliance or liability; patients often fear losing their children. The reality is nuanced:

• CARA: Requires notification when an infant is born affected by substances, but does not mandate a child abuse/neglect report at the federal level. States determine investigative thresholds (SAMHSA, n.d.).
• Punitive policies: Associated with delayed prenatal care, reduced adequacy, and lower postpartum visit rates. These policies breed fear and disengagement (Centers for Disease Control and Prevention, n.d.).
• Best practice: Treat substance use with support and evidence-based care; use warm language, clear expectations, and partner with patients to ensure safety and follow-through.

Clinical messaging:

• “We’re here to support you and your baby. Let’s talk about medication options that protect both of you. We’ll also discuss privacy, reporting requirements, and what we can do together to keep you connected to care.”

Care Transition Cornerstones: What Makes Programs Sustainable

We design programs for continuity between acute and community settings (JAMA Network, n.d.):

• Bridge prescriptions: Provide enough medication to cover the transition; avoid lapses that lead to relapse.
• Co-location: Health services, social supports, and mental health under one roof whenever possible.
• Patient preference: Offer telehealth, flexible scheduling, and local options that match patient life circumstances.
• Care navigation: Dedicated staff to orchestrate transitions, solve practical barriers, and keep momentum.

Clinic operations:

• Weekly multidisciplinary huddles to identify upcoming transitions and risk factors (e.g., recent incarceration, postpartum changes, housing instability).
• Use brief validated tools to assess risk and readiness (e.g., craving scales, PHQ-9, GAD-7, pain scores).
• Documented warm handoffs with explicit timelines and accountability.

Integrative Chiropractic Care: Pain, Autonomic Regulation, and Functional Gains

How chiropractic care fits into SUD treatment (BMJ, n.d.):

• Pain modulation: Manual therapy, joint mobilization, soft tissue techniques, and graded loading reduce nociceptive input and central sensitization. Less pain reduces self-medication pressure.
• Autonomic balance: Breathing mechanics, rib and diaphragm mobilization, and vagal tone training lower sympathetic dominance, reduce anxiety, and improve sleep—key for relapse prevention (Institute for Functional Medicine, n.d.).
• Movement re-education: Address dysfunctional motor patterns and deconditioned tissues to restore function and reinforce self-efficacy.
• Pain neuroscience education: Explain how pain and stress interact; empower patients to understand flare-ups and reduce catastrophizing (Carroll & Weiss, 2017).

Clinical observation:

• Patients with sciatica, low back pain, or whiplash respond favorably when manual therapies are paired with MOUD and mental health support. Improved function and reduced pain catastrophizing correlate with higher treatment retention. See insights at https://sciatica.clinic/ and my professional notes at https://www.linkedin.com/in/dralexjimenez/.

Functional Medicine and Nutrition: Reducing Inflammation and Supporting Neurobiology

Functional medicine complements addiction care by stabilizing biological systems (Institute for Functional Medicine, n.d.):

• Nutritional repletion: Omega-3 fatty acids, magnesium, vitamin D, iron, B-complex, and protein adequacy support neurotransmitter balance, reduce inflammation, and improve sleep quality.
• Gut-brain axis: Address dysbiosis, improve fiber intake, and consider probiotics to reduce systemic inflammation and affect mood regulation.
• Sleep hygiene and circadian support: Structured sleep routines, light exposure management, and breathing exercises improve cognitive function and reduce cravings (Centers for Disease Control and Prevention, n.d.).

Rationale:

• Chronic opioid use and high stress increase inflammatory markers and disrupt neurochemical balance. Restoring foundational physiologic resilience makes medications more effective and engagement more sustainable.

Rehabilitation and Personal Injury Care: Addressing Pain Drivers That Fuel Substance Use

In injury care cases (motor vehicle accidents, workplace injuries):

• Immediate goals: Reduce acute pain and prevent transition to chronic pain
• Techniques: Evidence-based chiropractic manipulation, soft tissue therapy, graded exposure, ergonomic optimization, and home exercise programming.
• Coordination: Medical oversight to ensure no contraindications (e.g., fractures, severe head injury), adjust medication plans, and manage comorbidities.

Link to SUD:

• Injury-related pain is a common pathway to opioid exposure. Integrative rehabilitation reduces the need for high-risk analgesic strategies and supports long-term function (BMJ, n.d.; JAMA Network, Nonjudgmental Care: Practical Communication That Changes Outcomes.

Small changes in communication have outsized effects (NIDA, 2018):

• Start with gratitude: “Thank you for coming.”
• Affirm barriers: “I know it took a lot to get here today.”
• Align goals: “Let’s find a plan that keeps you and your baby safe.”
• Provide choices: Telehealth, flexible scheduling, different therapy options.
• Be transparent about risks and laws: Share clear facts; avoid punitive tone.

Patients consistently report greater trust and willingness to return when they feel respected and supported. Engagement is the gateway to outcomes.

Emerging Topics: Genetics and GLP-1 Receptor Agonists

Genetics and SUD risk:

• Genetic predisposition is one factor among many (environmental, social, psychological) contributing to SUD risk.
• Direct-to-consumer and specialized genetic tests claim risk identification, but current limitations include:

• • Ethical concerns (bias, stigma)
  • Limited large-scale trials and predictive validity
  • Cost and access issues
  • Privacy concerns with third-party testing

Clinical approach:

• Genetics may inform future personalized prevention strategies, but present-day practice focuses on modifiable risks, supportive environments, and evidence-based treatments (New England Journal of Medicine, n.d.; Nature, n.d.).

GLP-1 receptor agonists:

• Medications like semaglutide and liraglutide have shown signals in reducing alcohol consumption in adults and lower risk of medical encounters for tobacco, cannabis, and opioid use disorder in observational claims analyses.
• While promising, more randomized controlled trials are needed to define indications, dosing, and safety profiles for SUD treatment (New England Journal of Medicine, n.d.).

Our approach:

• Monitor ongoing research; consider GLP-1 agonists primarily for approved indications (e.g., type 2 diabetes, obesity) while observing potential ancillary benefits on craving or consumption in appropriate cases under medical oversight.

Risk Mitigation: Naloxone, Fentanyl Awareness, and Harm Reduction

We prioritize harm reduction for all patients (Centers for Disease Control and Prevention, n.d.):

• Universal naloxone coprescribing and training
• Education on counterfeit pills and fentanyl contamination
• Safe use principles: Never use alone, test doses, avoid mixing depressants
• Overdose recognition and emergency response planning

Adolescent focus:

• Targeted education reduces the likelihood of experimenting with prescription drug misuse. Peer-informed programs amplify impact (Centers for Disease Control and Prevention, n.d.).

Quality, Safety, and Outcomes Tracking: Making Care Measurable

We employ modern, evidence-based methods (JAMA Network, n.d.):

• Standardized screening and outcome measures (pain scores, functional scales, mental health assessments)
• Medication adherence checks and side effect monitoring
• Event tracking (ED visits, hospitalizations, overdoses)
• Patient-reported outcomes on satisfaction, engagement, and barriers
• Continuous quality improvement cycles to refine protocols

Internal medicine oversight ensures medication safety and comorbidity management; chiropractic and rehabilitation teams document functional improvements and pain outcomes; care navigators track social determinants and resource linkages.

Real-World Implementation: How Our Clinic Operates Week to Week

• Monday huddles: Identify high-risk transitions (post-discharge, postpartum, post-release) and assign care navigator tasks.
• Telehealth slots reserved for patients with transport or childcare barriers.
• Integrated visit scheduling: Patients can see medical, chiropractic, and mental health providers in coordinated blocks.
• After-hours communication: Patient messaging for craving flares, pain spikes, or logistics issues; rapid response reduces crisis escalation.
• Documentation of warm handoffs with named receiving providers and scheduled times.

Why Integrative Chiropractic Care Matters In SUD Treatment

Physiological rationale:

• Pain and stress amplify craving through shared neural circuits. Reducing nociception and sympathetic drive alters the internal environment to favor recovery (Volkow et al., 2016; BMJ, n.d.).
• Movement and manual therapy support neuroplasticity, mood regulation, and sleep quality—core drivers of resilience (Institute for Functional Medicine, n.d.).

Clinical design:

• Match chiropractic intensity to patient stability (gentle techniques early; progress as tolerance and function improve).
• Combine with breathing drills, sleep hygiene, and nutritional strategies for whole-person benefits.
• Partner with internal medicine and mental health teams to ensure safety and congruence with medications and psychotherapies.

Putting It All Together: The Integrated Patient Journey

From hospital initiation of buprenorphine to outpatient stabilization, chiropractic pain management, functional nutrition, mental health support, and social services, every step has a rationale:

• Bridge prescriptions prevent lapses.
• Warm handoffs maintain trust.
• Co-located services reduce friction.
• Care navigation solves practical barriers.
• Chiropractic reduces pain and autonomic stress; functional medicine fortifies biology.
• Internal medicine oversight keeps treatment safe and coordinated.
• Harm reduction prevents fatal events.
• Outcome tracking ensures accountability and improvement.

This integrated path improves retention, lowers overdose risk, and helps patients recover function and meaning in their lives.

Key Takeaways: Simple Moves That Change Outcomes

• Provide 2–4 week bridge prescriptions at discharge.
• Schedule a follow-up within 48–72 hours; consider telehealth.
• Co-locate services and include care navigation; use nonjudgmental, person-centered language and choices.
• For pregnancy: Buprenorphine/methadone are safe; NOWS risk is not dose-dependent; postpartum dosing needs individualized adjustments.
• For justice-involved individuals: Emphasize tolerance changes, rapid re-initiation of MOUD, and harm reduction.
• For adolescents: Tailor to neurodevelopment; distribute naloxone; focus on mental health drivers; consider buprenorphine with careful dosing.
• Integrate chiropractic care to reduce pain and autonomic stress; coordinate under internal medicine oversight.

Summary and Practical Steps

We presented this comprehensive educational content synthesizing frontline realities and evidence-based strategies. To act now:

• Screen for SUD with non-stigmatizing tools
• Offer buprenorphine with flexible induction pathways
• Build nurse care manager follow-up flow
• Co-locate or tightly integrate counseling, chiropractic, and rehab
• Use peer supports for rapid engagement
• Plan warm handoffs across transitions
• Emphasize harm reduction throughout
• Track outcomes and iterate

Our multidisciplinary setup in El Paso—with Dr. Cardenas as Medical Director and collaborative physician—reflects an integrative model in which medical direction and chiropractic care work synergistically to deliver patient-centered SUD treatment.

References

• American Society of Addiction Medicine. The ASAM Criteria: Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions. (ASAM, n.d.)
• Substance Abuse and Mental Health Services Administration. Buprenorphine Treatment Practitioner Locator. (SAMHSA, n.d.)
• Substance Abuse and Mental Health Services Administration. TIP 63: Medications for Opioid Use Disorder. (SAMHSA, 2021)
• Providers Clinical Support System (PCSS). Clinical Mentoring for OUD Treatment. (PCSS, n.d.)
• National Institute on Drug Abuse. Principles of Drug Addiction Treatment: A Research-Based Guide. (NIDA, 2018)
• Volkow, N. D., Koob, G. F., & McLellan, A. T. Neurobiologic Advances from the Brain Disease Model of Addiction. New England Journal of Medicine, 374(4), 363–371. (Volkow et al., 2016)
• Babor, T. F., et al. Screening, Brief Intervention, and Referral to Treatment (SBIRT): Toward a Public Health Approach to SUD. (Babor et al., 2007)
• Carroll, K. M., & Weiss, R. D. The Role of Behavioral Interventions in SUD Treatment. Biological Psychiatry. (Carroll & Weiss, 2017)
• Degenhardt, L., et al. Global Burden of Disease for Opioid Use. The Lancet. (Degenhardt et al., 2018)
• American College of Obstetricians and Gynecologists. Opioid Use and Opioid Use Disorder in Pregnancy. (American College of Obstetricians and Gynecologists, n.d.)
• Centers for Disease Control and Prevention. Opioid Basics and Overdose Prevention. (Centers for Disease Control and Prevention, n.d.)
• JAMA Network. Bridge Clinics and Continuity of MOUD Care. (JAMA Network, n.d.)
• Advances in Addiction Neurobiology and Digital Therapeutics. (Nature, n.d.)
• Institute for Functional Medicine. Functional Medicine Frameworks for Inflammation and Recovery. (Institute for Functional Medicine, n.d.)
• Evidence Overview of Chiropractic Care and Pain Modulation. (BMJ, n.d.)
• New England Journal of Medicine. Emerging Evidence on GLP-1 Receptor Agonists and Substance Use. (New England Journal of Medicine, n.d.)

SEO tags: substance use disorder, opioid use disorder, buprenorphine initiation, methadone, ASAM levels of care, nurse practitioners SUD, motivational interviewing, contingency management, addiction consult services, harm reduction, chiropractic care for SUD, integrative medicine, functional medicine, pain management, personal injury care, care transitions, El Paso Texas clinic, Dr Alex Jimenez, Dr Maria Guadalupe Cardenas, primary care SUD integration, telehealth bridge clinics, peer support, sciatica clinic, pregnancy buprenorphine safety, postpartum dose adjustments, adolescent opioid use, justice-involved overdose risk, care navigation, co-located SUD services, GLP-1 receptor agonists in SUD, naloxone distribution, autonomic regulation, central sensitization, HPA axis, neurobiology of addiction, microdosing buprenorphine, high-dose buprenorphine induction, ACS inpatient consult, warm handoffs, outcome tracking